Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Reduced stem cell mobilization in mice receiving antibiotic modulation of the intestinal flora: involvement of endotoxins as cofactors in mobilization by Gerjo A. Velders, Ronald van Os, Henny Hagoort, Perry Verzaal, Henri F. L. Guiot, Ivan J. D. Lindley, Roel Willemze, Ghislain Opdenakker, and Willem E. Fibbe Blood Volume 103(1):340-346 January 1, 2004 ©2004 by American Society of Hematology The cytokine-induced mobilization of progenitor cells is decreased by treatment with ciprofloxacin and polymyxin B. Mice were treated with 100 mg/L ciprofloxacin, 70 mg/L polymyxin B, and 20 mg/L saccharose added to their drinking water for 1 week. Gerjo A. Velders et al. Blood 2004;103:340-346 ©2004 by American Society of Hematology Treatment with oral polymyxin B reduces cytokine-induced stem cell mobilization, while treatment with ciprofloxacin has no effect on IL-8– or G-CSF–induced mobilization. Gerjo A. Velders et al. Blood 2004;103:340-346 ©2004 by American Society of Hematology IL-8–induced mobilization is significantly reduced after treatment with metronidazol. Gerjo A. Velders et al. Blood 2004;103:340-346 ©2004 by American Society of Hematology In germ-free mice the IL-8–induced mobilization is significantly reduced. Gerjo A. Velders et al. Blood 2004;103:340-346 ©2004 by American Society of Hematology The IL-8–induced mobilization in decontaminated mice is restored after oral administration of endotoxins. Gerjo A. Velders et al. Blood 2004;103:340-346 ©2004 by American Society of Hematology The numbers of CAFCs in peripheral blood are decreased after pretreatment with ciprofloxacin and polymyxin B. Balb/c mice were treated with 100 mg/L ciprofloxacin, 70 mg/L polymyxin B, and 20 mg/L saccharose added to their drinking water. Gerjo A. Velders et al. Blood 2004;103:340-346 ©2004 by American Society of Hematology